Induced pluripotent stem cell-derived cardiac myocytes to assess anthracycline cardiotoxicity

25 August 2023 (17:15 - 18:00)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Lucas Van Aelst

University Hospitals (UZ) Leuven, Leuven (Belgium)

6 More presentations in this session

Presentation thumbnail

Biomimetic nanozymes target the heart to suppress ferroptosis for ameliorating doxorubicin-induced cardiotoxicity via synergetic effect of antioxidant stress and Nrf2/Hmox1 inhibition

Professor T. Liu (Tianjin, CN)

Abstract Slides Video

Presentation thumbnail

Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

Doctor J. Shanmuganathan (Aalborg, DK)

Abstract Slides Video

Presentation thumbnail

Mitochondrial function and oxidative stress in isolated peripheral blood mononuclear cells and trastuzumab-induced cardiotoxicity: a prospective longitudinal study

Assistant Professor K. Leemasawat (Chiang Mai, TH)

Abstract Slides Video

Presentation thumbnail

Circulating SerpinA3 as a novel indicator of cardiovascular dysfunction after anthracycline chemotherapy

Doctor H. Boen (Edegem, BE)

Abstract Slides Video

Presentation thumbnail

Protective effects of nicotinamide mononucleotide on radiation-related cardiac injury

Professor T. Liu (Tianjin, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Basic research in cardio-oncology

The Event

Event poster

ESC Congress 2023

25 August 2023 17:15 CET

You may be interested in

Congress Presentation

Preclinical models

Congress Presentation

Future directions

Congress Presentation

Deciphering doxorubicin-induced cardiotoxicity:insights at single-cell resolution

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources